AllenSYangMD

PubMed

• 21 citations
  Phase I Study of Fenretinide Delivered Intravenously in Patients with Relapsed or Refractory Hematologic Malignancies: A California Cancer Consortium Trial.
  Ann M. Mohrbacher, Allen S. Yang, Susan Groshen, Shivaani Kummar, Martin Gutierrez, Min H. Kang, Denice D. Tsao-Wei, C. Patrick Reynolds, Edward M. Newman, Barry J. Ma...> ;Clinical Cancer Research. 2017 Apr 18
• 4 citations
  Impact of Chromosomal Rearrangement upon DNA Methylation Patterns in Leukemia.
  Hyang-Min Byun, Shahrooz Eshaghian, Dan Douer, Jonathen Trent, Guillermo Garcia-Manero, Ravi Bhatia, Kim Siegmund, Allen S. Yang> ;Open Medicine. 2017 May 4
• 6 citations
  The failure of epigenetic combination therapy for cancer and what it might be telling us about DNA methylation inhibitors
  Allen S. Yang, Brandon J Yang> ;Epigenomics. 2016 Jan 1
• 3 citations
  Development of Romiplostim: A Novel Engineered Peptibody ☆
  Allen S. Yang> ;Seminars in Hematology. 2015 Jan 1
• 10 citations
  Relationship of different platelet response criteria and patient outcomes in a romiplostim myelodysplastic syndromes trial.
  Uwe Platzbecker, Mikkael A. Sekeres, Hagop M. Kantarjian, A.A.N. Giagounidis, Ghulam J. Mufti, Catherine Jia, Allen S. Yang, Pierre Fenaux> ;Leukemia. 2014 Dec 11
• 16 citations
  Development and validation of a model to predict platelet response to romiplostim in patients with lower-risk myelodysplastic syndromes.
  Mikkael A. Sekeres, Aristoteles Giagounidis, Hagop M. Kantarjian, Ghulam J. Mufti, Pierre Fenaux, Catherine Jia, Allen S. Yang, Uwe Platzbecker> ;British Journal of Haematology. 2014 Nov 1
• 102 citations
  A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome
  Mark Kirschbaum, Ivana Gojo, Stuart L. Goldberg, Christopher Bredeson, Lisa Kujawski, Allen S. Yang, Peter W. Marks, Paul Frankel, Xing Sun, Alessandra Tosolini, Josep...> ;British Journal of Haematology. 2014 Oct 1
• 122 citations
  Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia
  Aristoteles Giagounidis, Ghulam J. Mufti, Pierre Fenaux, Mikkael A. Sekeres, Jeff Szer, Uwe Platzbecker, Andrea Kuendgen, Gianluca Gaidano, Wieslaw Wiktor-Jedrzejczak,...> ;Cancer. 2014 Jun 15
• 60 citations
  A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine.
  Peter L. Greenberg, Guillermo Garcia-Manero, Michael R. Moore, Lloyd E. Damon, Gail J. Roboz, Kuolung Hu, Allen S. Yang, Janet Franklin> ;Leukemia & Lymphoma. 2013 Feb 1
• 50 citations
  A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk my...
  Eunice S Wang, Roger M. Lyons, Richard A. Larson, Sunil Gandhi, Delong Liu, Carmen Matei, Bart L. Scott, Kuolung Hu, Allen S. Yang> ;Journal of Hematology & Oncology. 2012 Nov 29
• 13 citations
  Mono-allelic retrotransposon insertion addresses epigenetic transcriptional repression in human genome
  Hyang-Min Byun, Kyu Heo, Kasey J Mitchell, Allen S. Yang> ;Journal of Biomedical Science. 2012 Feb 2
• 171 citations
  Predictors of global methylation levels in blood DNA of healthy subjects: a combined analysis
  Zhong Zheng Zhu, Lifang Hou, Valentina Bollati, Letizia Tarantini, Barbara Marinelli, Laura Cantone, Allen S. Yang, Pantel S. Vokonas, Jolanta Lissowska, Silvia Fustin...> ;International Journal of Epidemiology. 2012 Feb 1
• 17 citations
  AMD3100 sensitizes acute lymphoblastic leukemia cells to chemotherapy in vivo.
  Min Yu, E. J. Gang, Reshmi Parameswaran, Sonia Stoddart, Fei Fei, Sabine Schmidhuber, Eugene Park, Yao-Te Hsieh, Allen S. Yang, John Groffen, Nora Heisterkamp, Yong-Mi...> ;Blood Cancer Journal. 2011 Apr 1
• 7 citations
  Increased BCR promoter DNA methylation status strongly correlates with favorable response to imatinib in chronic myeloid leukemia patients.
  Youngil Koh, Dae-Young Kim, Sung-Hyo Park, Hyang-Min Byun, Inho Kim, Sung-Soo Yoon, Byoung Kook Kim, Eunkyung Park, Allen S. Yang, Seonyang Park> ;Oncology Letters. 2011 Jan 1
• 50 citations
  Identification of preferential target sites for human DNA methyltransferases
  Si Ho Choi, Kyu Heo, Hyang-Min Byun, Woojin An, Wange Lu, Allen S. Yang> ;Nucleic Acids Research. 2011 Jan 1
• 10 citations
  A phase I biological study of azacitidine (Vidaza™) to determine the optimal dose to inhibit DNA methylation.
  Ilan Bernstein, Hyang-Min Byun, Ann Mohrbacher, Dan Douer, Gerry Gorospe rd, Jeffrey Hergesheimer, Susan Groshen, Casey O'Connell, Allen S. Yang> ;Epigenetics. 2010 Nov 16
• 217 citations
  Hypomethylation of a LINE-1 promoter activates an alternate transcript of the MET oncogene in bladders with cancer.
  Erika M. Wolff, Hyang-Min Byun, Han Han, Shikhar Sharma, Peter W. Nichols, Kimberly D. Siegmund, Allen S. Yang, Peter A. Jones, Gangning Liang> ;Plos Genetics. 2010 Apr 22
• 67 citations
  Will DNA methylation inhibitors work in solid tumors? A review of the clinical experience with azacitidine and decitabine in solid tumors.
  Lisa A. Cowan, Sundeep Talwar, Allen S. Yang> ;Epigenomics. 2010 Feb 8
• 196 citations
  Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns
  Hyang-Min Byun, Kimberly D. Siegmund, Fei Pan, Daniel J. Weisenberger, Gary Kanel, Peter W. Laird, Allen S. Yang> ;Human Molecular Genetics. 2009 Dec 15
• 45 citations
  The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib
  David Masiello, Gerry Gorospe, Allen S. Yang> ;Journal of Hematology & Oncology. 2009 Nov 12
• 141 citations
  Selective Anchoring of DNA Methyltransferases 3A and 3B to Nucleosomes Containing Methylated DNA
  Shinwu Jeong, Gangning Liang, Shikhar Sharma, Joy C. Lin, Si Ho Choi, Han Han, Christine B. Yoo, Gerda Egger, Allen S. Yang, Peter A. Jones> ;Molecular and Cellular Biology. 2009 Oct 1
• 219 citations
  Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
  Tamer E. Fandy, James G. Herman, Patrick Kerns, Anchalee Jiemjit, Elizabeth A. Sugar, Si Ho Choi, Allen S. Yang, Timothy Aucott, Tianna Dauses, Rosalie Odchimar-Reissi...> ;Blood. 2009 Sep 24
• 439 citations
  Prenatal tobacco smoke exposure affects global and gene-specific DNA methylation.
  Carrie V. Breton, Hyang-Min Byun, Madé Wenten, Fei Pan, Allen S. Yang, Frank D. Gilliland> ;American Journal of Respiratory and Critical Care Medicine. 2009 Sep 1
• 114 citations
  Changes in DNA methylation of tandem DNA repeats are different from interspersed repeats in cancer
  Si Ho Choi, Scott Worswick, Hyang-Min Byun, Talia Shear, John C. Soussa, Erika M. Wolff, Dan Douer, Guillermo Garcia-Manero, Gangning Liang, Allen S. Yang> ;International Journal of Cancer. 2009 Aug 1
• 14 citations
  Gender and ethnic differences in chronic myelogenous leukemia prognosis and treatment response: a single-institution retrospective study
  Justin P. Lee, Elliott Aaron Birnstein, David Masiello, Dongyun Yang, Allen S. Yang> ;Journal of Hematology & Oncology. 2009 Jul 24
• Join now to see all